CY1113385T1 - Cysteine-protease inhibitors at home - Google Patents

Cysteine-protease inhibitors at home

Info

Publication number
CY1113385T1
CY1113385T1 CY20121101021T CY121101021T CY1113385T1 CY 1113385 T1 CY1113385 T1 CY 1113385T1 CY 20121101021 T CY20121101021 T CY 20121101021T CY 121101021 T CY121101021 T CY 121101021T CY 1113385 T1 CY1113385 T1 CY 1113385T1
Authority
CY
Cyprus
Prior art keywords
cysteine
home
protease inhibitors
cathepsin
compounds
Prior art date
Application number
CY20121101021T
Other languages
Greek (el)
Inventor
Jacques Yves Gauthier
Chun Sing Li
Christophe Mellon
Original Assignee
Merck Canada Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP05808098A external-priority patent/EP1817276B1/en
Application filed by Merck Canada Inc. filed Critical Merck Canada Inc.
Publication of CY1113385T1 publication Critical patent/CY1113385T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Αυτή η εφεύρεση αναφέρεται σε νέα κατηγορία ενώσεων, που παριστάνονται κατωτέρω, όπου τα R1, R2, R3, R4, R5, R6 R7, D και n ορίζονται στο παρόν, οι οποίες είναι αναστολείς πρωτεϊνο-κινάσης, περιλαμβανομένων, αλλά χωρίς περιορισμό σε αυτούς, αναστολέων καθεψινών Κ, L, S και Β. Αυτές οι ενώσεις είναι χρήσιμες για τη θεραπεία νόσων στις οποίες ενδείκνυται η αναστολή της επαναρρόφησης οστού, όπως η οστεοπόρωση.This invention relates to a new class of compounds, shown below, wherein R1, R2, R3, R4, R5, R6 R7, D and n are defined herein, which are protein kinase inhibitors, including but not limited to , cathepsin K, L, S, and B.

CY20121101021T 2004-11-23 2012-10-26 Cysteine-protease inhibitors at home CY1113385T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63040504A 2004-11-23 2004-11-23
EP05808098A EP1817276B1 (en) 2004-11-23 2005-11-18 Cathepsin cysteine protease inhibitors

Publications (1)

Publication Number Publication Date
CY1113385T1 true CY1113385T1 (en) 2016-06-22

Family

ID=58448863

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20121101021T CY1113385T1 (en) 2004-11-23 2012-10-26 Cysteine-protease inhibitors at home

Country Status (1)

Country Link
CY (1) CY1113385T1 (en)

Similar Documents

Publication Publication Date Title
CY1110214T1 (en) METHODS AND INTERMEDIATES
CY1112630T1 (en) HEDGEHOG SIGNAL POWDER SUSPENSIONS
CY1119106T1 (en) ANTIBODIES AGAINST MASP-2
DK1716162T3 (en) Phosphonates, amidomonophosphonates, amidobis phosphonates for the treatment of viral diseases
DK1836201T4 (en) Pyrrolidine Inhibitors of IAP.
DK1732933T3 (en) Pre-dressings for the treatment of dyslipidemia
CY1114284T1 (en) SULFONYL PYROLS AS HDAC SUSPENSIONS
CY1106640T1 (en) CRUZIPAIN AND OTHER CYSTEINE PROTEASE INHIBITORS
NL1026958A1 (en) Aryl or heteroarylamide compounds.
CY1112651T1 (en) Co-and heterocyclic compounds suitable as CETP suspensions
ITMI20030709A1 (en) MIXTURES OF STABILIZERS.
ITBO20030081A1 (en) PACK OF CIGARETTES.
DK1603915T3 (en) Substituted 8-pyridinyl-dihydrospiro-cycloalkyl-pyrimido-1,2-a-pyrimidin-6-one and 8-pyrimidinyl-dihydrospiro-cycloalkyl-pyrimido-1,2-a-pyrimidin-6-one derivatives and their use against neurogenerative diseases
NO20082118L (en) Heterocyclic CETP Inhibitors
EA200601029A1 (en) METHOD OF CLEANING FSH
DE50310977D1 (en) COMPACT MENTHOL
DK1628989T3 (en) New, 14- and 15-membered ring connections
NO20062022L (en) 1- (quinolinamino) - and 1- (isoquinolinamino) -substituted pentan-2-oils, process for their preparation and use of it as anti-inflammatory agents
CY1113385T1 (en) Cysteine-protease inhibitors at home
DK1628988T3 (en) Newly known 14- and 15-membered ring compounds
BR0318342B1 (en) gas burner.
CY1111182T1 (en) MOVEMENT SUSPENSIONS
UA8128S (en) SITKOVA CURTAIN, MOD. 2-45
ECSP003583A (en) CRYSTALLINE FORM III OF N- [4- (5- DIMETILAMINONAFTALEN-1-SULFONILAMINO) FENIL] -3-HIDROXI-2,2-DIMETILPROPIONAMIDA (CASE LEA 33884-EC)
CY1115764T1 (en) IAP SUSPENSIONS